CLICK TO SHARE
Mario Tama / Getty ImagesA health care worker gives a motorist a nasal swab test at a drive-in coronavirus testing center at M.T.O. Shahmaghsoudi School of Islamic Sufism on Aug. 11, 2020, in Los Angeles, California. (Mario Tama / Getty Images)
The Food and Drug Administration issued an emergency-use authorization Wednesday for what it called a “fast and efficient” COVID-19 test developed by Abbott Laboratories that will be available for $5 and which can provide results within 15 minutes of testing.
The FDA said its emergency-use authorization allows Abbott to market “the first antigen test where results can be read directly from the testing card, a similar design to some pregnancy tests. This simple design is fast and efficient for healthcare providers and patients and does not need the use of an analyzer.”
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card. This means people will know if they have the virus in almost real-time,” Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a news release.
“Due to its simpler design and the large number of tests the company anticipates making in the coming months, this new antigen test is an important advancement in our fight against the pandemic,” he said.
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE